ClinicalTrials.govpublic full text
To Assess the Pharmacokinetics, Safety, and Tolerability of AZD8233 in Participants With Chronic Kidney Disease (CKD), End Stage Renal Disease (ESRD) and Healthy Participants.
end stage renal disease, end stage renal disease (esrd), renal impairment, pharmacokinetic, pharmacodynamic, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 910374
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.